Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: margie who wrote (3955)	3/24/1998 2:11:00 PM
From: Steve Fancy	of 6136

Margie, the news I'm anticipating has been continually reiterated in PaineWebber research documents. I copied the following from my post 3853 on this thread. UPCOMING MILESTONES Marketing approval for Viracept in Japan and other countries Q1 1998 - Initiation of Phase Il/Ill clinical studies for MMP inhibitor (AG3340) Q1 1998 - Clinical results of Phase 1 dose ranging study for GART inhibitor (AG2034) Not sure how this news may affect the stock. Hopefully at least enough to inspire the more skeptical to re-evaluate the pipeline and the stock. It seems we need non-Viracept related news out of AGPH to finally break 40. Ya never know, but any reassurance that AGPH will not be a one drug company could cause a nice move upwards. News should come in the next two weeks? Margie, thanks for your research once again. I, being a close scrip follower (trying to track sales), appreciate your daily scrip breakdown. I hadn't thought of this somewhat obvious method of evaluating the data. sf sf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next